compound semaglutide ban update Will compounded be banned? How compounders plan to continue

van Hall G

GLP-1 receptor agonists reduce inflammatory cytokines, improve insulin resistance, aid gut health, and help lower the chronic inflammation that drives many forms of arthritis, as well as metabolic and heart diseases. Are GLP-1 medications safe, and who should not use them

References: EDS Types | The Ehlers Danlos Society : The Ehlers Danlos Society (ehlers-danlos.com) Ehlers-Danlos Syndrome: Symptoms, Causes, Treatments (clevelandclinic.org) Collagen: The Fibrous Proteins of the Matrix Molecular Cell Biology NCBI Bookshelf (nih.gov) Ehlers-Danlos syndromes | Genetic and Rare Diseases Information Center (GARD) an NCATS Program (nih.gov) Ehlers-Danlos syndromes NHS (www.nhs.uk) Accurate diagnosis and self-care support for women with lipoedema | Practice Nursing (magonlinelibrary.com) Subcutaneous Adipose Tissue Diseases: Dercum Disease, Lipedema, Familial Multiple Lipomatosis, and Madelung Disease Endotext NCBI Bookshelf (nih.gov) Lipedema: A Painful Adipose Tissue Disorder | IntechOpen Lipedema: friend and foe (nih.gov) Subcutaneous Adipose Tissue Diseases: Dercum Disease, Lipedema, Familial Multiple Lipomatosis, and Madelung Disease Endotext NCBI Bookshelf (nih.gov) A novel therapeutic strategy for EhlersDanlos syndrome based on nutritional supplements ScienceDirect * These statements have not been evaluated by the Food and Drug Administration

GLP-1-related weight loss generally improves these scores through better power-to-weight ratio

SOD and GPx are critical for decreasing oxidative stress